恶毒的万科:在患有末期脏疾病的患者身上,万科胺诱导的皮肤小血管血管炎
Michelle Carrasquel1,2, Khaleel Quasem1, Taylor Patterson1
1Internal Medicine, McLaren Greater Lansing Hospital, Lansing, USA.
Cureus
|February 16, 2026
概括
范科米辛很少会引起免疫媒介血管炎,呈皮肤病变和低血小板. 早期识别和停止使用万科米辛会导致快速康复,特别是在患有脏疾病的患者中.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 皮肤病学 皮肤病学
- 传染性疾病 传染性疾病
背景情况:
- 范科米辛是严重的グラム阳性感染的关键抗生素.
- 免疫媒介的小血管血管炎是一种罕见但严重的万科米辛的不良反应.
- 末期病患者的风险可能会增加或呈现不同的情况.
研究的目的:
- 报告一种由万科米辛诱导的白细胞结晶性血管炎病例.
- 要强调早期识别功能障碍患者的重要性.
- 强调立即停止使用万科米辛,以快速恢复.
主要方法:
- 一个43岁的男性患有末期脏病,接受血液透析的病例报告.
- 皮肤病变的临床观察和实验室发现 (血小板缺血症,乳酸蛋白,炎症标志物).
- 停止使用万科米辛,并转换为达普米辛.
主要成果:
- 患者在开始服用万科米辛药三天后出现了明显的紫色病变.
- 实验室检测显示,血小板缺血进展,炎症标志物升高.
- 停用万科米导致在48小时内快速的临床改善.
结论:
- 范科米辛可以诱导白细胞结晶性血管炎,呈皮肤病变和血小板减少.
- 早期识别和停止使用万科米辛对于迅速康复至关重要.
- 患有功能障碍的患者可能会经历加速发病,并受益于没有皮质类固醇的早期干预.
相关概念视频
Renal Failure: Dose Adjustments
502
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
502
Acute Kidney Injury IV: Diagnostic Studies and Prevention
354
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
354
Hemodialysis II: Procedure and Complications
1.0K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.0K
Acute Kidney Injury III: Clinical Manifestations
993
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
993
Chronic Kidney Disease II: Clinical Manifestations
705
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
705
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
237
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
237


